Abiopharma

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): CHANGE IN SUBSTANTIAL SHAREHOLDERS INTEREST - CHING CHIAT KWONG

General Announcement: RESPONSE TO QUESTIONS RECEIVED FROM A SHAREHOLDER PRIOR TO THE COMPANYS ANNUAL GENERAL MEETING

General Announcement: Monthly Update on GCTea Outlets 2B Ltd, GCTea Outlets 2A Ltd, GCTea Ltd, PPR Ryde (NSW) Pty Ltd

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest by Director - Jiang Honghui

CoStar Data Shows Midlands Big-Box Market Reaches Turning Point as Supply Starts to Fall

New Form ARS - Cadre Holdings, Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001104659-26-048195 <b>Size:</b> 4 MB

New Form ARS - Entrada Therapeutics, Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001689375-26-000023 <b>Size:</b> 48 MB

Annual General Meeting :

New Form ARS - Clarus Corp <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001104659-26-048194 <b>Size:</b> 18 MB

General Announcement: RESPONSE TO QUESTIONS RECEIVED AHEAD OF ANNUAL GENERAL MEETING TO BE HELD ON 30 APRIL 2026

General Announcement: Changes to the Composition of the Board and Board Committees

New Form DEFA14A - Entrada Therapeutics, Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001689375-26-000022 <b>Size:</b> 1 MB

New Form DEF 14A - Clarus Corp <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001104659-26-048192 <b>Size:</b> 4 MB

New Form DEF 14A - Entrada Therapeutics, Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001689375-26-000021 <b>Size:</b> 1 MB

New Form DEF 14A - Cadre Holdings, Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001104659-26-048191 <b>Size:</b> 3 MB